My ePortfolio Register   

Novel high risk genes of melanoma

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 18.05.17
Views: 1097

Prof Nick Hayward - QIMR Berghofer, Brisbane, Australia

Prof Hayward speaks with ecancer at EADO 2017 about genomic sequencing of families with a history of melanoma to determine high-risk genes.

He notes candidates among DNA repair pathways which have been cut short, and which targeted therapies may offer clinical benefit for these, and other, mutations.

ecancer's filming has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.

Related videos

follow us

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence